Insider · CIK 0001252524

EMSTER KURT VON

Reports to the SEC for 8 companies · REDWOOD CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001252524

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-31	JSPRJasper Therapeutics, Inc. · Stock Option (Right to BuyA Award	Director	AAward	+7,500 sh	—	—	7,500
2025-07-03	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2024-06-06	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−90K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−27.7K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−67K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−49.2K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2024-03-22	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2024-01-24	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,010
2023-09-29	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−15.9K sh	$15.68	−$250K	90,000
2023-09-29	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−943 sh	—	—	0
2023-09-29	CymaBay Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+15.9K sh	$5.00	+$79.6K	105,921
2023-09-29	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,357 sh	—	—	0
2023-09-29	CymaBay Therapeutics, Inc.Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−5,249 sh	—	—	0
2023-09-29	CymaBay Therapeutics, Inc.Stock Appreciation RightM Exercise/Conversion	Director	MExercise/Conversion	−3,372 sh	—	—	0
2023-06-07	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+47K sh	—	—	47,000
2023-04-13	JSPRJasper Therapeutics, Inc.S Sale	Director	SSale	−9,075 sh	$1.49	−$13.5K	21,175
2023-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-10-12	JSPRJasper Therapeutics, Inc.A Award	Director	AAward	+30.3K sh	—	—	30,250
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+78K sh	—	—	78,045
2022-01-25	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+67K sh	—	—	67,000
2021-06-02	PCVXVaxcyte, Inc. · Stock option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,000
2021-05-18	VERAVera Therapeutics, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−2.19M sh	—	—	0
2021-05-18	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+773K sh	$11.00	+$8.5M	2,960,231
2021-05-18	VERAVera Therapeutics, Inc.C Conversion	Director	CConversion	+2.19M sh	—	—	2,187,504
2021-05-17	VERAVera Therapeutics, Inc.P Purchase	Director	PPurchase	+17.8K sh	$12.04	+$215K	17,828
2021-05-13	VERAVera Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+9,925 sh	—	—	9,925
2021-01-26	CymaBay Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+32K sh	—	—	32,000
2020-06-16	PCVXVaxcyte, Inc.C Conversion	Director	CConversion	+2.19M sh	—	—	2,185,415
2020-06-16	PCVXVaxcyte, Inc. · Series D Preferred StockC Conversion	Director	CConversion	−299K sh	—	—	0
2020-06-16	PCVXVaxcyte, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−455K sh	—	—	0
2020-06-16	PCVXVaxcyte, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−1.22M sh	—	—	0
2020-06-16	PCVXVaxcyte, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−2.19M sh	—	—	0
2020-06-16	PCVXVaxcyte, Inc.P Purchase	Director	PPurchase	+12.5K sh	$16.00	+$200K	4,168,718
2020-06-16	PCVXVaxcyte, Inc.C Conversion	Director	CConversion	+299K sh	—	—	4,156,218
2020-06-16	PCVXVaxcyte, Inc.C Conversion	Director	CConversion	+455K sh	—	—	3,857,301
2020-06-16	PCVXVaxcyte, Inc.C Conversion	Director	CConversion	+1.22M sh	—	—	3,402,489
2020-06-11	PCVXVaxcyte, Inc. · Stock option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-11	PCVXVaxcyte, Inc. · Stock option (right to buy)A Award	Director	AAward	−40K sh	—	—	40,000
2020-05-15	CymaBay Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+49.2K sh	—	—	49,245
2019-01-29	CymaBay Therapeutics, Inc.Stock option (right to buy)A Award	Director	AAward	+27.7K sh	—	—	27,705
2018-12-18	CymaBay Therapeutics, Inc.S Sale	Director	SSale	−53.5K sh	$7.43	−$397K	131,036

Recent filings

Accepted (ET)
Aug 44
EMSTER KURT VON0001213900-26-085189
SEC(opens sec.gov)
Jul 34
EMSTER KURT VON0001213900-25-061501
SEC(opens sec.gov)
Jun 104
EMSTER KURT VON0001213900-24-051398
SEC(opens sec.gov)
Mar 224
EMSTER KURT VON0000950170-24-035435
SEC(opens sec.gov)
Jan 264
EMSTER KURT VON0001062993-24-001416
SEC(opens sec.gov)
Sep 294
EMSTER KURT VON0001062993-23-018622
SEC(opens sec.gov)

Companies

Address

C/O JASPER THERAPEUTICS, INC. 2200 BRIDGE PKWY, SUITE #102

REDWOOD CITY, CA, 94065